Low-gluten, nontransgenic wheat engineered with CRISPR/Cas9.

Sánchez-León S, Gil-Humanes J, Ozuna CV, Giménez MJ, Sousa C, Voytas DF, Barro F. · 2018

Read Low-gluten, nontransgenic wheat engineered with CRISPR/Cas9. by Sánchez-León S, Gil-Humanes J, Ozuna CV, Giménez MJ, Sousa C, Voytas DF, Barro F. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5867031.txt.

Introduction

Sánchez and co-authors engineer wheat with far less gluten using CRISPR/Cas9. Their article appeared in Plant Biotechnology Journal. Gluten proteins in wheat trigger coeliac disease in susceptible people. The alpha-gliadin gene family holds the most potent triggers. One peptide, the 33-mer, drives most of the immune response. The team designed guide RNAs to cut near that peptide's code.

They produced twenty-one mutant wheat lines in bread and durum types. Some lines had up to 35 gliadin genes altered. Immune reactivity fell by 85 percent in the best results. Lines free of foreign DNA were also identified. No off-target cuts were found at checked sites. The lines could supply low-gluten foods in the future.

Catalog record

CREATORSánchez-León S, Gil-Humanes J, Ozuna CV, Giménez MJ, Sousa C, Voytas DF, Barro F.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5867031

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Low‐gluten, nontransgenic wheat engineered with CRISPR/Cas9 By Susana Sánchez‐León, Javier Gil‐Humanes, Carmen V Ozuna, María J Giménez, Carolina Sousa, Daniel F Voytas, Francisco Barro Published in: Plant Biotechnology Journal DOI: 10.1111/pbi.12837 ABSTRACT Summary Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by the ingestion of gluten proteins from wheat, barley and rye. The α‐gliadin gene family of wheat contains four highly stimulatory peptides, of which the 33‐mer is the main immunodominant peptide in patients with coeliac. We designed two sgRNAs to target a conserved region adjacent to the coding sequence for the 33‐mer in the α‐gliadin genes. Twenty‐one mutant lines were generated, all showing strong reduction in α‐gliadins. Up to 35 different genes were mutated in one of the lines of the 45 different genes identified in the wild type, while immunoreactivity was reduced by 85%. Transgene‐free lines were identified, and no off‐target mutations have been detected in any of the potential targets. The low‐gluten, transgene‐free wheat lines described here could be used to produce low‐gluten foodstuff and serve as source material to introgress this trait into elite wheat varieties. Keywords: coeliac disease, α‐gliadins, CRISPR/Cas9 INTRODUCTION Wheat is one of the most widely grown crops in the world and a major component of the human diet. Wheat grain contains gluten proteins, which are responsible for the unique viscoelastic properties of wheat‐derived foods; however, they also trigger certain pathologies in susceptible individuals. Amongst these, the α‐gliadin family is the main protein group associated with the development of coeliac disease and noncoeliac gluten sensitivity, which affect more than 7% of the Western population (Mustalahti et al., 2010; Sapone et al., 2011). In bread wheat, α‐gliadins are encoded by approximately 100 genes and pseudogenes (Ozuna et al., 2015) organized in tandem at the Gli‐2 loci of chromosomes 6A, 6B and 6D. Traditional mutagenesis and plant breeding have failed to obtain low immunogenic wheat varieties for patients with coeliac. Here, we show that CRISPR/Cas9 technology can be used to precisely and efficiently reduce the amount of α‐gliadins in the seed kernel, providing bread and durum wheat lines with reduced immunoreactivity for gluten‐intolerant consumers. RESULTS AND DISCUSSION To precisely modify the immunoreactive α‐gliadin genes, we designed two sgRNAs (sgAlpha‐1 and sgAlpha‐2) (Figure 1a) to target conserved regions adjacent to the coding sequence for the immunodominant epitope in wheat gluten, a protease‐resistant, 33‐amino acid peptide that contains six overlapping copies of three distinct, tandemly organized epitopes (DQ2.5‐glia‐α1a, PFPQPELPY; DQ2.5‐glia‐α2, PQPELPYPQ; and DQ2.5‐glia‐α1b, PYPQPELPY) (Tye‐Din et al., 2010). The CRISPR/Cas9 constructs were transformed into two bread wheat (BW028 and TAH53) and one durum wheat (DP) cultivars, resulting in twenty‐one (15 bread wheat and 6 durum wheat) T0 transgenic lines. DNA was isolated from leaves of 17 T1 transgenic plants (5 BW208, 4 TAH53, and 8 DP) and the corresponding wild‐type varieties, and PCR amplicons encompassing the sgAlpha‐1 and sgAlpha‐2 target sites were subjected to Illumina high‐throughput DNA sequencing (Figure 1a, Table S1). We observed considerable variability in the bread wheat and durum wheat wild‐type sequences, due to randomly distributed SNPs and differences in the number of encoded epitopes in the 33‐mer region (Figure S1). As expected, a number of sequences were pseudogenes with premature stop codons, and frameshift mutations in the C‐terminus (Figure S2). We found 45, 52 and 43 different α‐gliadin sequences that were highly represented (frequencies higher than 0.3%) in BW208, THA53 and DP, respectively. Of these, 35, 13 and 29 were, respectively, mutated by CRISPR/Cas9 (Figure S3). The mutation spectrum in the α‐gliadins was characterized in the various T1 transgenic plants (Figure 1b–d, Table S2, Figures S4–S6). Due to the presence of the Cas9 expression vector in some of the mutant lines, the frequency of mutations observed might be overestimated, as a consequence of somatic mutations. However, in most cases we observed similar mutation frequencies in T1 plants generated from the same T0 plant, with or without Cas9—that is V467 (+Cas9, 5.18% NHEJ) and V468 (−Cas9, 5.17% NHEJ), both derived from T0 plant #20 (Table S2). [Figure: Gene editing of α‐gliadins in bread wheat. (a) Schematic of a typical α‐gliadin gene indicating the different protein domains. Two of the peptide sequences involved in gluten intolerance (p31‐43 and the 33‐mer) are represented by red arrows, whereas the target sequences for the sgRNAs (sgAlpha‐1 and sgAlpha‐2) are represented by blue arrows. Black arrows indicate primers used for Illumina sequencing. (b–d) Illumina sequencing of the α‐gliadin genes of 3 T1 BW208 mutant lines (T544, T545 and T553) transformed with sgAlpha‐2. (b) Alignment of the different deletion types found at the target locus of sgAlpha‐2; (c) Alignment of the different insertions at the target locus of sgAlpha‐2; and (d) frequency of the different type of insertions and deletions.] In general, sgAlpha‐2 was more effective than sgAlpha‐1. It should be noted that lower regeneration was observed in transgenic plants containing sgAlpha1 (0.3% transformation frequency) than plants with sgAlpha2 (1% transformation frequency). Therefore, a possible toxic effect might be also affecting the NHEJ activity of sgAlpha‐1, favouring the regeneration of those lines in which the level of expression of sgAlpha1 is lower, and consequently the mutation frequency. The highest mutation frequencies (62.3%–75.1%) were observed in the BW208‐derived lines transformed with sgAlpha‐2 (Table S2). Three of these T1 lines (T544, T545 and T553) had insertions and deletions (indels) at the target site of between +36 and +158 bp and −1 and −126 bp, respectively (Figure 1b–d). Line T545 had the highest mutation frequency of all analysed lines: ~75% of the sequence reads had indels (Table S2). Transgenic lines of cv DP and cv THA53 showed lower indel frequencies, ranging between 1.50% and 14.77% and 5.16%–7.86%, respectively. Interestingly, the typical −1bp deletion normally observed with CRISPR/Cas9 was very frequent in two of the DP sgAlpha‐2 lines (22.4%–35.6%), but only represented 0.18%–2.9% of the mutations found in the BW208 sgAlpha‐2 lines (Figures 1 and S4). The −1bp deletion was not found in the THA53 lines or in the sgAlpha‐1 lines. The +1 bp insertion, also reported as a typical mutation of CRISPR/Cas9, was only found at low frequency in one of the sgAlpha‐1 lines. A possible explanation for this observation is the preference of certain types of deletions due to microhomology‐mediated repair. The target sites of sgAlpha‐1 and sgAlpha‐2 are highly repetitive, and as shown in Figure S7, repeats between 3 and 36 bp are commonly found flanking the targeted break. The repeats could explain the bias in favour of some of the most frequent mutations observed, such as the −75 and −11 bp deletions in BW208 sgAlpha‐2 lines, the −15 bp deletion in DP sgAlpha‐2 lines and the −36 bp deletion in all BW208, TAH53 and DP lines. DNA insertions represented up to 19% of the total indels (Line T544, Table S2), and they were found to be either fragments of the transformation vectors or other α‐gliadin genes, probably inserted by microhomology‐mediated repair. These results demonstrate that high mutation frequency and specificity can be achieved using CRISPR/Cas9 to modify complex genomic loci such as the α‐gliadin gene family in bread and durum wheat. To assess the impact of the observed mutations on seed protein composition, gliadin and glutenin content in T1 half‐seeds was qualitatively assessed by A‐PAGE and SDS‐PAGE,

Read the complete text